These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21235603)

  • 1. Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series.
    Rahier JF; Papay P; Salleron J; Sebastian S; Ellul P; Teich N; Fiorino G; Blaha B; Garcia-Sanchez V; Haas T; Van Gossum A; Abitbol V; Yazdanpanah Y; Chaparro MC
    Aliment Pharmacol Ther; 2011 Feb; 33(4):499-500. PubMed ID: 21235603
    [No Abstract]   [Full Text] [Related]  

  • 2. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.
    Rahier JF; Papay P; Salleron J; Sebastian S; Marzo M; Peyrin-Biroulet L; Garcia-Sanchez V; Fries W; van Asseldonk DP; Farkas K; de Boer NK; Sipponen T; Ellul P; Louis E; Peake ST; Kopylov U; Maul J; Makhoul B; Fiorino G; Yazdanpanah Y; Chaparro M;
    Gut; 2011 Apr; 60(4):456-62. PubMed ID: 21270121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease.
    Rahier JF; Yazdanpanah Y; Viget N; Travis S; Colombel JF
    Aliment Pharmacol Ther; 2010 Jan; 31(1):5-10. PubMed ID: 19814744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pearls for H1N1 influenza vaccination.
    Marcotte GV
    J Allergy Clin Immunol; 2010 Apr; 125(4):951-2; author reply 952. PubMed ID: 20226509
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sub-optimal H1N1 vaccine uptake by immunocompromised inflammatory bowel disease patients.
    Hanna M; Poullis A
    Clin Med (Lond); 2011 Jun; 11(3):301. PubMed ID: 21902095
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
    Greenhawt MJ; Chernin AS; Howe L; Li JT; Sanders G
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):387-93. PubMed ID: 21055666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.
    Mackay HJ; McGee J; Villa D; Gubbay JB; Tinker LM; Shi L; Kuruvilla J; Wang L; MacAlpine K; Oza AM
    J Clin Virol; 2011 Mar; 50(3):212-6. PubMed ID: 21168361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doctors asked to be vigilant in following novel H1N1 vaccination recommendations.
    Currier M
    J Miss State Med Assoc; 2009 Sep; 50(9):317-9. PubMed ID: 20812445
    [No Abstract]   [Full Text] [Related]  

  • 10. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. . . . And an editorial view.
    Child Health Alert; 2010 Feb; 28():1-2. PubMed ID: 20437618
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe pandemic (H1N1) 2009 influenza with false negative direct fluorescent antibody assay: case series.
    Kapelusznik L; Patel R; Jao J; Patel G; Daefler S; Labombardi V; Calfee D
    J Clin Virol; 2009 Nov; 46(3):279-81. PubMed ID: 19716765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine.
    Fernandes P; Jorge S; Lopes JA
    Am J Kidney Dis; 2010 Jul; 56(1):185-6. PubMed ID: 20620684
    [No Abstract]   [Full Text] [Related]  

  • 15. Appropriate response to influenza A (H1N1) virus vaccination in patients with inflammatory bowel disease on maintenance immunomodulator and/or biological therapy.
    Molnár T; Farkas K; Jankovics I; Melles M; Nagy F; Szepes Z; Wittmann T
    Am J Gastroenterol; 2011 Feb; 106(2):370-2. PubMed ID: 21301464
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
    Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
    Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pandemic vaccines].
    Floret D
    Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
    [No Abstract]   [Full Text] [Related]  

  • 18. [New modalities of care in influenza A/H1N1].
    Chevillotte J
    Rev Infirm; 2009 Sep; (153):7. PubMed ID: 19771800
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.